Listener Training for Parkinson's Disease
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Listener Training for Parkinson's Disease?
Research on similar treatments, like the Lee Silverman Voice Treatment (LSVT/LOUD), shows that training vocal loudness can improve speech and communication in Parkinson's patients. This suggests that Listener Training, which may involve similar auditory and vocal exercises, could also help improve communication for those with Parkinson's Disease.12345
Is Listener Training safe for humans?
How does the Listener Training treatment for Parkinson's Disease differ from other treatments?
Listener Training is unique because it focuses on improving auditory processing and communication, which are often impaired in Parkinson's Disease. Unlike traditional treatments that primarily address motor symptoms, this approach targets non-motor symptoms by enhancing the ability to hear and understand speech, potentially improving overall communication and quality of life for patients.110111213
What is the purpose of this trial?
Listener training offers a promising avenue for improving communication for people with dysarthria due to Parkinson's disease by offsetting the intelligibility burden from the patient onto their primary communication partners. Here, we employ a repeated-measures, randomized controlled trial to establish the efficacy of listener training for patients with PD and their primary communication partners. This translational work will establish a new realm of clinical practice in which the intelligibility impairments in PD are addressed by training partners to better understand dysarthric speech, thus elevating communication outcomes and participation in daily life.
Research Team
Stephanie Borrie, PhD
Principal Investigator
Utah State University
Kaitlin Lansford, PhD
Principal Investigator
Florida State University
Sarah Yoho Leopold, PhD
Principal Investigator
Utah State University
Eligibility Criteria
This trial is for people with Parkinson's disease who have speech difficulties (dysarthria). It focuses on improving how well they are understood by training their main conversation partners. Participants must be diagnosed with Parkinson's and experience communication challenges.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training
Listeners receive training to improve understanding of dysarthric speech from patients with Parkinson's Disease
Follow-up
Participants are monitored for retention of intelligibility improvements and other communication benefits
Treatment Details
Interventions
- Listener Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Utah State University
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Florida State University
Collaborator